CAS RN: 5170-41-2
2,1,3-benzothiadiazole-4,7-dicarboxylic acid
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250827
100mg / 250mg / 1g
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 5170-41-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥97%
0
Out of Stock
Beijing
Inquiry
5170-41-2 / 2,1,3-benzothiadiazole-4,7-dicarboxylic acid
Standard CAS: 5170-41-2
Multi CAS: No
Basic Information
copy
CAS
5170-41-2 copy
Multi CAS
No copy
Molecular Formula
C8H4N2O4S copy
Molecular Weight
224.200000 copy
Exact Mass
223.989178 copy
InChI
InChI=1S/C8H4N2O4S/c11-7(12)3-1-2-4(8(13)14)6-5(3)9-15-10-6/h1-2H,(H,11,12)(H,13,14) copy
InChIKey
KLJMFMKPFLWVRM-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
9 copy
Rotatable bonds
2 copy
H-bond acceptors
5 copy
H-bond donors
2 copy
Molar refractivity
51.33 copy
TPSA
100.38 copy
LogP / Solubility
WLOGP
1.09 copy
MLOGP
0.96 copy
XLogP3
0.8 copy
Consensus LogP
0.95 copy
Log S (ESOL)
-2.23 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.18 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.26 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.32 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy